Ordine to be discontinued

The Therapeutic Goods Administration has provided advice regarding the discontinuation of all Ordine oral liquid medicines in Australia Mundipharma has advised that it will discontinue all four strengths of its Ordine (morphine) oral liquid. This includes: ORDINE morphine hydrochloride trihydrate 1mg/mL oral solution bottle AUST R: 150219 Market deletion date: 31 Dec 2023 ORDINE morphine hydrochloride

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Rural, regional workforce insufficient
Next Focusing on patient privacy